Laboratory Corp. of America Holdings (NYSE:LH)

Can a random number generator (www.random.org) produce the best 100 stock picks that will beat the market over the years? Let’s find out. :)

My process, for those interested:
I use www.random.org number generator to produce a number between 1 and 7,801. There are 7,801 stocks available to choose on the Motley Fool CAPS Game. Once I get a number, I go to the list, find that stock, and select that stock to outperform for the next five years.

Low cost provider well positioned for obamacare and many managed care lives with UNH and others

Fool yoder motley fool: this post is almost impossible to write on my iPhone. You are denying all your members my brilliant healthcare picks due to your mobile ignorance. If this was a touch easier maybe I would be telling members that the big labs are losing share to the increasingly big hospital networks that are increasingly armed with efficient scale diagnostics instrumentation, logistics, higher reimbursement rates (given hospital fee schedule, and xxxxxxxxx so annoyed I won't even get to yyyyyyy

Anytime the growth rate of EPS exceeds the PE, I am interested and confident that it will outperform the market. I must first be confident in the company's financial security and consistentcy of managment.

Genetic testing

M* ultimate stockpickers

1x - 5/3

Strong fundamentals, and a growing patient base, should outperform based on industry leading profitability

would love to get it on a pull back -- long term out performer in a duopoly market.

Low cost leader. Check the population/age curve and watch what happens with healthcare reform. Testing demand will go up and LH is my pick.

Low Cost leader in the medical industry. Other companies will be hurt if prices come down, but LabCorp has great profit margins.

The company is concentrating efforts to develop (or acquire) technology for genetic testing, with its associated higher margins than regular routine blood tests. Coupled with its existing DNA testing facility, plus the recently acquired genetics testing arm of Genzyme, LabCorp is well-positioned for the testing needs of the future. In addition, its efforts to automate the testing process (which is currently very labor-intensive) will help keep costs low to remain competitive.

Sustained itself in difficult industry/time, potential to rise and undervalued.

Good numbers, growth industry.

As hospitals consolidate they are acquiring primary care practices in their communities. These practices are now directing much of their lab tests to Lab Corp. True, the office & waiting rooms of Lab Corp are far from glamorous but they are highly efficient, fast, reliable and low cost. Plus you can order your own lab testing online with no need for a physician referral if you like.

Great margins and great management

Re-rec from SA... watching this one a bit closer now.

10

Purely technical decision related to overall near-term weakness in the healthcare sector vs. the market. This is a great company I've owned long before and made a nice return that would have been even nicer if I held it longer. Using this near-term pan to help me track my expected pullback in different healthcare issues I like to hopefully be able to get back into them at lower prices.